LCS Total Knee System
Depuy, Inc. · Decision date Oct 5, 2026
What did the FDA decide?
The FDA recorded decision OK30 on 2026-10-05 for P830055/S380, a 30-Day Notice supplement to the LCS® Total Knee System held by Depuy, Inc. The supplement reason is listed as a process change affecting manufacturer, sterilizer, packager or supplier. The recorded statement describes removal of a duplicate inspection performed at the DePuy Cork facility for the Attune CR Femoral Components of the LCS® Total Knee System.
This action concerns a manufacturing inspection step for a named femoral component within an existing knee prosthesis system, not a new approval of the system as a whole. The device category is a semi-constrained, metal/polymer, mobile-bearing patellofemoral-tibial knee prosthesis under product code NJL, specialty Orthopedic. The public documentation includes no supporting documents, so the inspection's scope, effective date and any conditions attached to OK30 remain unknown.
Whether the removed duplicate inspection affected released inventory or required any field action is not stated in the available record, and no clinical or legal conclusion should be drawn from the decision code alone.
FDA approval order statement
removal of a duplicate inspection performed at the DePuy Cork facility for the Attune CR Femoral Components of the LCS Total Knee System
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Orthopedic
- Decision date
- Oct 5, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P830055/S380
- Regulatory pathway
- PMA supplement
- Applicant
- Depuy, Inc.
- Product code
- NJL
- Decision code
- OK30
- Decision date
- Oct 5, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing.
- Applicant
- Depuy, Inc.
- Product code
- NJL
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P830055/S374 · Related supplement
LCS(R) TOTAL KNEE SYSTEM, specifically ATTUNE Cruciate Retaining (CR), Posterior Stabilized (PS) and Revision Femoral C
P830055/S372 · Related supplement
ATTUNE Rotating Platform (RP) Total Knee System, ATTUNE Cementless Rotating Platform (RP) Knee System, ATTUNE Revision R
P830055/S376 · Related supplement
Attune Rotating Platform (RP) Total Knee System and the DePuy P.F.C. Sigma Rotating Platform (RP) Total Knee System an
P830055/S351 · Related supplement
Attune Revision Knee System
P830055/S375 · Related supplement
LCS Total Knee System
P830055/S380 received
Application receipt date recorded by FDA.
P830055/S380 · FDA decision
30-Day Notice
P830055/S377 · Related supplement
ATTUNE Rotating Platform (RP) Total Knee System, ATTUNE Revision Rotating Platform (RP) Total Knee System, and M.B.T. Re
P830055/S379 · Related supplement
ATTUNE Revision Knee System
P830055/S378 · Related supplement
LCS Knee System
P830055/S381 · Related supplement
ATTUNE Rotating Platform (RP) Total Knee System, and ATTUNE Revision Rotating Platform (RP) Knee System
Timeline entries are records held by MedtechLedger for P830055. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P830055
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Depuy, Inc. | PMA supplement | Sep 3, 2026 | FDA | |
| Depuy, Inc. | PMA supplement | Sep 9, 2026 | FDA | |
| Depuy, Inc. | PMA supplement | Sep 10, 2026 | FDA | |
Attune Revision Knee SystemP830055/S351 | Depuy, Inc. | PMA supplement | Sep 21, 2026 | FDA |
LCS Total Knee SystemP830055/S375 | Depuy, Inc. | PMA supplement | Sep 25, 2026 | FDA |
| Depuy, Inc. | PMA supplement | Oct 8, 2026 | FDA | |
ATTUNE Revision Knee SystemP830055/S379 | Depuy, Inc. | PMA supplement | Oct 9, 2026 | FDA |
LCS Knee SystemP830055/S378 | Depuy, Inc. | PMA supplement | Oct 27, 2026 | FDA |
| Depuy, Inc. | PMA supplement | Oct 27, 2026 | FDA |
Explore the linked device profile
Other records with product code NJL
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
NexGen LPS-Flex/LPS Mobile Bearing Knee SystemP060037/S100 | Zimmer, Inc. | PMA supplement | Oct 16, 2026 | FDA |
| Zimmer, Inc. | PMA supplement | Sep 24, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Depuy, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- P.O. Box 988, 700 Orthopaedic Dr., Warsaw, IN, 46581
Sources and methodology
- Original FDA record: P830055/S380
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records






